Rational design of respiratory syncytial virus dimeric F-subunit vaccines in protein and mRNA forms.
Li J, Ma X, Xu Z, Guo W, Peng R, Zhang Y, Meng Y, Zhao J, Wang Q, Li S, Chen J, Guo Y, Lu X, Wang Q, Guo Y, Jia MA, Li Y, Zhang Y, Li S, Du P, Wang Q, Gao GF, Qi J.
EBioMedicine. 2025 Sep;119:105902. doi: 10.1016/j.ebiom.2025.105902. Epub 2025 Aug 30.
PMID:40886405
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
Meng CY, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang FS, Fu YX, Peng H.
Gut. 2023 Aug;72(8):1544-1554. doi: 10.1136/gutjnl-2022-327059. Epub 2022 Oct 31.
Construction of a Delivery Platform for Vaccine Based on Modified Nanotubes: Sustainable Prevention against Plant Viral Disease, Simplified Preparation Method, and Protection of Plasmid.
Liu S, Su C, Zhang D, Song Z, Wang X, Wang J, Yuan X.
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R.
Clin Infect Dis. 2023 Feb 8;76(3):e590-e598. doi: 10.1093/cid/ciac703.